Firm Assessing Covid Vaccine Harm Replaced After Costs Spiral To £48m

Nearly £50m of taxpayers' money has been paid by nan NHS to an outsourced patient assessing claims of aesculapian harm caused by vaccines, nan BBC has found.

The fig is 8 times nan magnitude primitively estimated for nan appraisal activity carried retired by Crawford & Company Adjusters - and almost £20m much than nan full truthful acold awarded to those injured aliases bereaved arsenic a consequence of Covid vaccines.

The firm's five-year contract, initially estimated to beryllium worthy £6m, has much than a twelvemonth near to tally - nevertheless a caller institution will commencement taking complete nan activity successful nan coming months.

The costs of nan activity by Crawford, and "level of statement spend", is because nan measurement of claims "has exceeded nan anticipated levels", an NHS spokesperson told nan BBC.

More than 22,000 claims related to Covid vaccines person been made truthful far, astir of them relating to nan jab manufactured by AstraZeneca - but only astir 1% person resulted successful compensation payouts.

They are handled by nan UK-wide Vaccine Damage Payment Scheme (VDPS), for which Crawford has carried retired aesculapian assessments since March 2022.

One rule professor told nan BBC that "the quality of nan [Crawford] statement was peculiar", and that because of nan "significant uncertainty" astatine nan clip it was drawn up, they would person expected to spot a shorter 1 that had a headdress connected nan number of claims processed.

Responding to questions arsenic to why costs were allowed to spiral for truthful long, an NHS spokesperson said nan magnitude of clip it takes nationalist assemblage organisations to procure contracts "can vary", and nan quality of nan statement was "complex".

Crawford - whose genitor institution is based successful nan US - was approached for comment, but nan patient referred nan BBC to nan NHS.

The money paid to Crawford for providing aesculapian assessments is abstracted from nan money awarded to group who person suffered arsenic a consequence of vaccine damage.

Created successful 1979, nan VDPS presently offers a one-off tax-free costs of £120,000 if it is medically proven that, connected nan equilibrium of probability, a vaccine has caused terrible disabilities.

The benefits of vaccination are good documented. The AstraZeneca Covid jab is credited pinch redeeming millions of lives. And yet for those who were harmed by nan jab, nan resulting injuries are devastating.

There person been much than 3 times nan number of claims nether nan VDPS for Covid jabs than during nan erstwhile 4 decades for each nan eligible vaccines combined.

Despite nan increase, nan number of successful claims has been small. As of mid-November past year, 249 group had received payouts for harm caused by Covid vaccinations.

The payments totalled £29.8m, funded by nan UK authorities and paid separately from nan Crawford contract.

Monthly NHS payments to Crawford escalated soon aft it began nan appraisal activity for nan VDPS, BBC study shows.

The NHS appears to person begun scrutinising nan statement pinch nan supplier arsenic costs spiralled because of nan number of claims.

The estimated worth of Crawford's original five-year statement was £6m - nevertheless this fig was reached 14 months in, successful May 2023.

The caller statement pinch a different supplier was only announced connected 5 January this year.

Moves to look for a caller supplier started successful September 2023, but successful nan interim, spending continued to rise.

Eighteen months later, Crawford was paid £5.9m for a azygous period - almost nan aforesaid arsenic nan full contract's first estimated value, nan BBC has discovered.

Given nan uncertainties astir nan imaginable number of claims, an master has questioned why nan NHS didn't take a statement that would person allowed it to "review nan situation" erstwhile much reliable information was available.

"Using patient contracts successful uncertain situations carries important commercialized risks," says Albert Sanchez-Graells, a professor astatine nan University of Bristol Law School who has been researching NHS contracts for much than 15 years.

When asked by nan BBC astir nan formulation of nan woody and whether mistakes had been made, an NHS spokesperson said location were "several factors which power a procurement strategy and conception of nan contract", without elaborating further.

Responsibility for carrying retired nan aesculapian appraisal activity is being taken complete by Maximus UK Services Limited - different supplier whose genitor institution is based successful nan US. The nonstop day erstwhile it will commencement is yet to beryllium confirmed.

The caller statement is group to tally for 5 years and is estimated astatine £27m, acold much than nan worth of nan statement awarded to Crawford successful 2021, but still importantly little than nan magnitude paid to it complete nan people of its agreement.

Of nan caller contract, nan NHS spokesperson said its worth had been calculated based connected nan complaint of caller claims received - and could "be flexed" if that changes.

Potential reforms to nan VDPS are presently being reviewed by Health Secretary Wes Streeting.

Its workings were considered arsenic portion of nan Covid inquiry, and will beryllium addressed successful a study owed to beryllium published connected 16 April.

Get our flagship newsletter pinch each nan headlines you request to commencement nan day. Sign up here.